annual current liabilities:
$30.35B+$5.16B(+20.48%)Summary
- As of today (August 2, 2025), NVO annual total current liabilities is $30.35 billion, with the most recent change of +$5.16 billion (+20.48%) on December 31, 2024.
- During the last 3 years, NVO annual current liabilities has risen by +$15.20 billion (+100.32%).
- NVO annual current liabilities is now at all-time high.
Performance
NVO Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$34.25B+$3.90B(+12.86%)Summary
- As of today (August 2, 2025), NVO quarterly total current liabilities is $34.25 billion, with the most recent change of +$3.90 billion (+12.86%) on March 31, 2025.
- Over the past year, NVO quarterly current liabilities has increased by +$10.29 billion (+42.97%).
- NVO quarterly current liabilities is now at all-time high.
Performance
NVO quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NVO Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.5% | +43.0% |
| 3 y3 years | +100.3% | +138.7% |
| 5 y5 years | +243.2% | +267.0% |
NVO Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.3% | at high | +122.5% |
| 5 y | 5-year | at high | +243.2% | at high | +237.4% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
NVO Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $34.25B(+12.9%) |
| Dec 2024 | $30.35B(+20.5%) | $30.35B(-2.8%) |
| Sep 2024 | - | $31.21B(+15.7%) |
| Jun 2024 | - | $26.97B(+12.6%) |
| Mar 2024 | - | $23.96B(-4.9%) |
| Dec 2023 | $25.19B(+44.7%) | $25.19B(+3.1%) |
| Sep 2023 | - | $24.44B(+6.9%) |
| Jun 2023 | - | $22.86B(+18.3%) |
| Mar 2023 | - | $19.32B(+11.0%) |
| Dec 2022 | $17.41B(+14.9%) | $17.41B(+1.1%) |
| Sep 2022 | - | $17.22B(+11.8%) |
| Jun 2022 | - | $15.40B(+7.3%) |
| Mar 2022 | - | $14.35B(-5.3%) |
| Dec 2021 | $15.15B(+30.4%) | $15.15B(+9.9%) |
| Sep 2021 | - | $13.78B(+18.3%) |
| Jun 2021 | - | $11.65B(+2.1%) |
| Mar 2021 | - | $11.41B(-1.8%) |
| Dec 2020 | $11.62B(+31.3%) | $11.62B(+3.8%) |
| Sep 2020 | - | $11.19B(+10.2%) |
| Jun 2020 | - | $10.15B(+8.8%) |
| Mar 2020 | - | $9.33B(+5.5%) |
| Dec 2019 | $8.84B(+6.6%) | $8.84B(-4.3%) |
| Sep 2019 | - | $9.24B(+7.2%) |
| Jun 2019 | - | $8.62B(+4.8%) |
| Mar 2019 | - | $8.23B(-0.8%) |
| Dec 2018 | $8.30B(+9.4%) | $8.30B(+7.9%) |
| Sep 2018 | - | $7.69B(+0.8%) |
| Jun 2018 | - | $7.63B(+4.5%) |
| Mar 2018 | - | $7.30B(-3.7%) |
| Dec 2017 | $7.58B(+12.4%) | $7.58B(+6.2%) |
| Sep 2017 | - | $7.14B(+6.0%) |
| Jun 2017 | - | $6.74B(-4.0%) |
| Mar 2017 | - | $7.02B(+4.1%) |
| Dec 2016 | $6.75B(+12.7%) | $6.75B(+7.8%) |
| Sep 2016 | - | $6.26B(+0.8%) |
| Jun 2016 | - | $6.21B(-0.6%) |
| Mar 2016 | - | $6.24B(+4.3%) |
| Dec 2015 | $5.99B(+8.8%) | $5.99B(+3.0%) |
| Sep 2015 | - | $5.81B(+0.2%) |
| Jun 2015 | - | $5.80B(-4.7%) |
| Mar 2015 | - | $6.09B(+10.7%) |
| Dec 2014 | $5.50B(+22.7%) | $5.50B(+7.4%) |
| Sep 2014 | - | $5.12B(+17.8%) |
| Jun 2014 | - | $4.34B(-10.6%) |
| Mar 2014 | - | $4.86B(+8.4%) |
| Dec 2013 | $4.48B(+16.9%) | $4.48B(-3.4%) |
| Sep 2013 | - | $4.64B(+4.5%) |
| Jun 2013 | - | $4.44B(+0.8%) |
| Mar 2013 | - | $4.40B(+14.8%) |
| Dec 2012 | $3.84B | $3.84B(-15.5%) |
| Sep 2012 | - | $4.54B(+13.8%) |
| Jun 2012 | - | $3.99B(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $3.94B(+8.7%) |
| Dec 2011 | $3.62B(+9.9%) | $3.62B(-2.5%) |
| Sep 2011 | - | $3.71B(+2.9%) |
| Jun 2011 | - | $3.61B(+4.5%) |
| Mar 2011 | - | $3.46B(+4.8%) |
| Dec 2010 | $3.30B(+27.7%) | $3.30B(+6.5%) |
| Sep 2010 | - | $3.09B(+3.1%) |
| Jun 2010 | - | $3.00B(+6.6%) |
| Mar 2010 | - | $2.82B(+9.1%) |
| Dec 2009 | $2.58B(+5.9%) | $2.58B(+1.4%) |
| Sep 2009 | - | $2.54B(+8.2%) |
| Jun 2009 | - | $2.35B(-6.5%) |
| Mar 2009 | - | $2.51B(+3.1%) |
| Dec 2008 | $2.44B(+16.9%) | $2.44B(+4.9%) |
| Sep 2008 | - | $2.32B(-0.2%) |
| Jun 2008 | - | $2.33B(-4.9%) |
| Mar 2008 | - | $2.45B(+17.4%) |
| Dec 2007 | $2.08B(+16.0%) | $2.08B(+1.2%) |
| Sep 2007 | - | $2.06B(+7.4%) |
| Jun 2007 | - | $1.92B(+0.5%) |
| Mar 2007 | - | $1.91B(+6.2%) |
| Dec 2006 | $1.80B(+7.2%) | $1.80B(-8.0%) |
| Sep 2006 | - | $1.95B(+11.6%) |
| Jun 2006 | - | $1.75B(+2.7%) |
| Mar 2006 | - | $1.71B(+1.7%) |
| Dec 2005 | $1.68B(+25.6%) | $1.68B(+11.6%) |
| Sep 2005 | - | $1.50B(+3.6%) |
| Jun 2005 | - | $1.45B(+11.7%) |
| Mar 2005 | - | $1.30B(-2.8%) |
| Dec 2004 | $1.33B(+18.7%) | $1.33B(+9.9%) |
| Sep 2004 | - | $1.21B(+10.9%) |
| Jun 2004 | - | $1.09B(-4.6%) |
| Mar 2004 | - | $1.15B(+2.1%) |
| Dec 2003 | $1.12B(+33.6%) | $1.12B(+33.6%) |
| Dec 2002 | $841.27M(+18.5%) | $841.27M(+18.5%) |
| Dec 2001 | $709.85M(-11.3%) | $709.85M(-11.3%) |
| Dec 2000 | $800.07M(+5.1%) | $800.07M(+5.1%) |
| Dec 1999 | $761.33M(-11.4%) | $761.33M(-11.4%) |
| Dec 1998 | $858.95M(+10.2%) | $858.95M(+10.2%) |
| Dec 1997 | $779.56M(-5.6%) | $779.56M(-5.6%) |
| Dec 1996 | $825.71M(+16.4%) | $825.71M(+16.4%) |
| Dec 1995 | $709.25M(-5.8%) | $709.25M(-5.8%) |
| Dec 1994 | $752.74M(+38.1%) | $752.74M(+38.1%) |
| Dec 1993 | $545.20M(-0.4%) | $545.20M(-0.4%) |
| Dec 1992 | $547.28M(-16.1%) | $547.28M(-16.1%) |
| Dec 1991 | $652.11M(-9.5%) | $652.11M(-9.5%) |
| Dec 1990 | $720.85M(+30.8%) | $720.85M(+30.8%) |
| Dec 1989 | $551.25M(+39.1%) | $551.25M(+39.1%) |
| Dec 1988 | $396.36M(+14.2%) | $396.36M(+14.2%) |
| Dec 1987 | $347.05M(+16.2%) | $347.05M(+16.2%) |
| Dec 1986 | $298.79M(+67.2%) | $298.79M(+67.2%) |
| Dec 1985 | $178.69M(+7.8%) | $178.69M(+7.8%) |
| Dec 1984 | $165.83M | $165.83M |
FAQ
- What is Novo Nordisk A/S annual total current liabilities?
- What is the all time high annual current liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual current liabilities year-on-year change?
- What is Novo Nordisk A/S quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly current liabilities year-on-year change?
What is Novo Nordisk A/S annual total current liabilities?
The current annual current liabilities of NVO is $30.35B
What is the all time high annual current liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total current liabilities is $30.35B
What is Novo Nordisk A/S annual current liabilities year-on-year change?
Over the past year, NVO annual total current liabilities has changed by +$5.16B (+20.48%)
What is Novo Nordisk A/S quarterly total current liabilities?
The current quarterly current liabilities of NVO is $34.25B
What is the all time high quarterly current liabilities for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total current liabilities is $34.25B
What is Novo Nordisk A/S quarterly current liabilities year-on-year change?
Over the past year, NVO quarterly total current liabilities has changed by +$10.29B (+42.97%)